FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran

Peer Review reports

Original Submission
28 May 2021	Submitted	Original manuscript
14 Jun 2021	Reviewed	Reviewer Report
13 Oct 2021	Reviewed	Reviewer Report
4 Nov 2021	Author responded	Author comments - Behnaz Amernia
Resubmission - Version 2
4 Nov 2021	Submitted	Manuscript version 2
Publishing
22 Nov 2021	Editorially accepted
3 Dec 2021	Article published	10.1186/s12876-021-02038-3

Back to article page